Back to Journals » Clinical Ophthalmology » Volume 15

Original Research

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma

       
Total article views   HTML views PDF downloads Totals
6,774 Dovepress* 6,133+ 497 6,630
PubMed Central* 641 109 750
Totals 6,774 606 7,380
*Since 24 June 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar